In a recent study, the elevation of pro-inflammatory molecules such as IL-6 and leptins, as well as a reduction in anti-inflammatory cytokines such as IL-13, has been shown in the central nervous system (CNS) of obese MS patients (31). This evidence concerns the gene LEP and myeloid sarcoma.